🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study About Contrast Media

RecruitingNAAges 18 Years - anyAllUniversity of Tartu
NCT05678023 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients 18 years or older * Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation * No peritonitis present, no need for an emergent surgery * Patients sign an informed consent Exclusion Criteria: * Patients younger than 18 yeas * Patients with mechanical small bowel obstruction caused by incarcerated hernias * Patients with mechanical small bowel obstruction caused by carcinomatosis * Patients with paralytic small bowel obstruction * Patients who have undergone surgery within 6 weeks * Patients who do not want to be enrolled in the study
💊

What it tests

  • Effect on contrast media depending on the time of its administratsion
📍

Where

1 site
Tartu University Hospital
Tartu, Estonia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy